Global Nanostructured Drug Market Study 2015-2025, by Segment (Liposomes, Polymeric Micelles, Solid lipid Nanoparticles, … …), by Market (Cancer and Tumors, Autoimmune Disorders), by Company (Merck, Pfizer, Novartis, … …)

  • Report Id : AMP82041
  • Published : Dec, 2018
  • Category : Healthcare & Pharma
  • Publisher : 99Strategy
  • Pages : 70
Overview

Ample Market Research published a report, titled, "Global Nanostructured Drug Market Study 2015-2025, by Segment (Liposomes, Polymeric Micelles, Solid lipid Nanoparticles, … …), by Market (Cancer and Tumors, Autoimmune Disorders), by Company (Merck, Pfizer, Novartis, … …)". The study provides insights on the present scenario as well as the growth prospects of the “Global Nanostructured Drug Market Study 2015-2025, by Segment (Liposomes, Polymeric Micelles, Solid lipid Nanoparticles, … …), by Market (Cancer and Tumors, Autoimmune Disorders), by Company (Merck, Pfizer, Novartis, … …)”. It presents the qualitative and quantitative analysis of the industry by analyzing the current trends, market growth drivers, restraints, opportunities, and various marketing strategies adopted by the players.

  • Snapshot

    The global Nanostructured Drug market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Liposomes

    Polymeric Micelles

    Solid lipid Nanoparticles

    Microemulsion and Nanoemulsion

    Nanosuspension

    Demand Coverage (Market Size & Forecast, Consumer Distribution):

    Cancer and Tumors

    Autoimmune Disorders

    Company Coverage (Sales data, Main Products & Services etc.):

    Merck

    Pfizer

    Novartis

    Abbott

    GlaxoSmithKline

    Roche

    Sanofi

    Eli Lilly

    Astrazeneca

    Johnson & Johnson

    Celgene

    Novavax

    Stryker

    Gilead Sciences

    OSI Pharmaceuticals

    Kadmon Pharmaceuticals

    Samyang Biopharm

    Mitsubishi Pharma

    Kaken Pharmaceutical

    Selecta Biosciences

    Par Pharmaceutical

    Cerulean Pharma

    Navidea Biopharmaceuticals

    Lummy

    Major Region Market

    North America

    Europe

    Asia-Pacific

    South America

    Middle East & Africa

     

  • Table of Content

    1 Industry Overview

    1.1 Nanostructured Drug Industry

    1.1.1 Overview

    1.1.2 Products of Major Companies

    1.2 Market Segment

    1.2.1 Industry Chain

    1.2.2 Consumer Distribution

    1.3 Price & Cost Overview

    2 Nanostructured Drug Market by Type

    2.1 By Type

    2.1.1 Liposomes

    2.1.2 Polymeric Micelles

    2.1.3 Solid lipid Nanoparticles

    2.1.4 Microemulsion and Nanoemulsion

    2.1.5 Nanosuspension

    2.2 Market Size by Type

    2.3 Market Forecast by Type

    3 Global Market Demand

    3.1 Segment Overview

    3.1.1 Cancer and Tumors

    3.1.2 Autoimmune Disorders

    3.2 Market Size by Demand

    3.3 Market Forecast by Demand

    4 Major Region Market

    4.1 Global Market Overview

    4.1.1 Market Size & Growth

    4.1.2 Market Forecast

    4.2 Major Region

    4.2.1 Market Size & Growth

    4.2.2 Market Forecast

    5 Major Companies List

    5.1 Merck (Company Profile, Sales Data etc.)

    5.2 Pfizer (Company Profile, Sales Data etc.)

    5.3 Novartis (Company Profile, Sales Data etc.)

    5.4 Abbott (Company Profile, Sales Data etc.)

    5.5 GlaxoSmithKline (Company Profile, Sales Data etc.)

    5.6 Roche (Company Profile, Sales Data etc.)

    5.7 Sanofi (Company Profile, Sales Data etc.)

    5.8 Eli Lilly (Company Profile, Sales Data etc.)

    5.9 Astrazeneca (Company Profile, Sales Data etc.)

    5.10 Johnson & Johnson (Company Profile, Sales Data etc.)

    5.11 Celgene (Company Profile, Sales Data etc.)

    5.12 Novavax (Company Profile, Sales Data etc.)

    5.13 Stryker (Company Profile, Sales Data etc.)

    5.14 Gilead Sciences (Company Profile, Sales Data etc.)

    5.15 OSI Pharmaceuticals (Company Profile, Sales Data etc.)

    5.16 Kadmon Pharmaceuticals (Company Profile, Sales Data etc.)

    5.17 Samyang Biopharm (Company Profile, Sales Data etc.)

    5.18 Mitsubishi Pharma (Company Profile, Sales Data etc.)

    5.19 Kaken Pharmaceutical (Company Profile, Sales Data etc.)

    5.20 Selecta Biosciences (Company Profile, Sales Data etc.)

    5.21 Par Pharmaceutical (Company Profile, Sales Data etc.)

    5.22 Cerulean Pharma (Company Profile, Sales Data etc.)

    5.23 Navidea Biopharmaceuticals (Company Profile, Sales Data etc.)

    5.24 Lummy (Company Profile, Sales Data etc.)

    6 Conclusion

     

This is a single user license, allowing one specific user access to the product.

This is an enterprise license, allowing all employees within your organisation access to the product.

The report will sent to you in PDF format via email.

Need Assistance ?